In particular, whether significant NT-proBNP changes correlate with more formal measures of PCD and longer-term outcomes such as ascites recurrence and mortality, and whether routine early administration of higher concentrations of supplemental albumin in cirrhotic patients with cardiac dysfunction can improve clinical outcomes. The gene discussed is ALB; the disease is Ascites.